| Literature DB >> 35415299 |
Houjuan Zhu1, Justin Mah Jian Qiang1,2, Chen Gang Wang1, Chui Yu Chan1, Qiang Zhu1, Enyi Ye1,3, Zibiao Li1,3, Xian Jun Loh1.
Abstract
Flexible polymeric patches find widespread applications in biomedicine because of their biological and tunable features including excellent patient compliance, superior biocompatibility and biodegradation, as well as high loading capability and permeability of drug. Such polymeric patches are classified into microneedles (MNs), hydrogel, microcapsule, microsphere and fiber depending on the formed morphology. The combination of nanomaterials with polymeric patches allows for improved advantages of increased curative efficacy and lowered systemic toxicity, promoting on-demand and regulated drug administration, thus providing the great potential to their clinic translation. In this review, the category of flexible polymeric patches that are utilized to integrate with nanomaterials is briefly presented and their advantages in bioapplications are further discussed. The applications of nanomaterials embedded polymeric patches in non-cancerous diseases were also systematically reviewed, including diabetes therapy, wound healing, dermatological disease therapy, bone regeneration, cardiac repair, hair repair, obesity therapy and some immune disease therapy. Alternatively, the limitations, latest challenges and future perspectives of such biomedical therapeutic devices are addressed.Entities:
Keywords: Biomedical scaffolds; Flexible polymeric patches; Hydrogel; Microneedle; Nanomaterials; Non-cancer therapy
Year: 2022 PMID: 35415299 PMCID: PMC8971585 DOI: 10.1016/j.bioactmat.2022.03.034
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Scheme 1Nanomaterials integrated polymeric patches for noncancerous disease treatment.
Non-cancer therapeutics of nanomaterials integrated flexible polymeric patches.
| Type | Characteristics of patch | Nanomaterials | Application | Property of treatment | Analytes | Ref. |
|---|---|---|---|---|---|---|
| MN | Dissolvability; biocompatibility | Black phosphorus | Wound healing | Oxygen Responsive | 3T3 cells; STZ-induced diabetic mice | 37 |
| MN | Excellent biocompatibility; sufficient stiffness | H2O2-responsive polymeric vesicles (PVs) | Diabetes therapy | H2O2-responsive | HeLa cells; STZ-Induced diabetic mice | 75 |
| MN | High mechanical strength; biodegradation and long-term biocompatibility | MSC-derived exosomes; UK5099-loaded PLGA nanoparticles | Hair regrowth | Sustained drug release capacity | human dermal fibroblast cells, C57BL/6J mouse | 77 |
| MN | Improved the stiffness | Glucose responsive vesicles (GRVs) | Diabetes therapy | Glucose-responsive; hypoxia-sensitive; rapid responsiveness | STZ-induced diabetic mice | 137 |
| MNs | Biocompatibility; biodegradability | Self-assembled polymeric nanosized vesicles | Diabetes therapy | Hypoxia-sensitive | Mouse islets β-cells; STZ-induced type-1 diabetic SD mice | 138 |
| MN | Enhanced loading capability; bioavailability | Dual-sensitive, glucose-responsive polymersomes (d-GRPs) | Diabetes therapy | Hypoxia and H2O2 dual-sensitive | STZ-induced type 1 diabetic C57BL/6J mice | 139 |
| MN | Fast responsiveness; rapid hypoglycemic effect; no risk of hypoglycemia | Supramolecular polymer vesicles (PVs) | Diabetes therapy | pH- and glucose -responsive | 3T3 cells; diabetic SD rats | 141 |
| MN | Improved mechanical strength | GOx immobilized copper phosphate mineralized particles (m-GOx); Ex4 integrated calcium phosphate (m-Ex4) | Diabetes therapy | pH- and, glucose-responsive; closed-loop release | C57BL/6 db/db diabetic mice | 142 |
| MN | Improved mechanical strength | ZnO quantum dots (ZnO QDs) capped mesoporous bioactive glasses (MBGs) | Diabetes therapy | pH- and glucose-triggered and | 3T3-L1 cells; diabetes SD rats | 143 |
| MN | Remarkable mechanical strength; slower solubility properties; high strength; slow-release performance; Strong mechanical strength; excellent swelling property | CaCO3 microparticles (INSCaCO3 MPs) | Diabetes therapy | Swelling-responsive | MCF-7 cells; STZ induced diabetic rats | 144 |
| MN | Biocompatibility; improved robustness | HRP-CaP particles | Diabetes sensing | pH- and glucose-responsive; hyperglycemia sensing | STZ-induced diabetic mice | 145 |
| MN | Fast response; excellent biocompatibility; dissolvable | Polymeric vesicles (PVs) | Diabetes therapy | Glucose- and H2O2-responsive | STZ-induced type 2 diabetic SD rats | 146 |
| MN | Excellent mechanical strength and toughness | Mesoporous silica nanoparticles (MSNs) | Diabetes therapy | H2O2-responsive | STZ-Induced diabetes SD rats | 147 |
| MN | Enhanced strength | Nano-sized complex micelles (NCs) | Diabetes therapy | H2O2 and pH cascade-responsive | STZ-induced type-1 diabetic SD mice | 148 |
| MN | Improved mechanical strength | Gold nanoclusters (GNCs) | Diabetes therapy | Glucose-responsive | STZ-induced type-1 diabetic SD mice | 149 |
| MN | High loading efficiency; minimal toxicity | Polymer-grafted hollow mesoporous silica nanoparticles (HMSNs-PAPBA) | Diabetes therapy | Glucose-responsive | 3T3-L1 cells; STZ rats | 150 |
| MN | High biocompatibility and biodegradability; relatively low melting point; dissolving; low cost; high loading capacity | Prussian blue nanoparticles (PB NPs) | Diabetes therapy | NIR light triggered | Muscle cells; STZ induced type 2 diabetic SD rats | 151 |
| MN | Dissolvable; excellent flexibility and toughness | Cu7S4 nanoparticles | Diabetes therapy | NIR light-triggered | HeLa cells; STZ induced type 2 diabetic SD rats | 152 |
| MN | Biodegradable; excellent flexibility and toughness; enhanced mechanical property | Hollow mesoporous SiO2 | Diabetes therapy | NIR-responsive | STZ induced type 2 diabetic SD rats | 153 |
| MN | Dissolvability | Proretinal nanoparticles (PRN) | Retinoids therapy | Sustained release | German domestic pigs | 175 |
| MN | Excellent aqueous solubility; rapidly dissolving; good biocompatibility | Bleomycin-loaded HA | Hypertrophic scar therapy | Rapid release | HHSFs cells | 176 |
| MN | Improved mechanical strength; improved loading of drug | HA/HP- | Hypertrophic scar therapy | Accelerated self-degradation | HSFbs cells, New Zealand rabbits | 177 |
| MN | Dissolvability | Mesoporous silica-coated upconversion nanoparticles (UCNPs@mSiO2) | Abnormal scar therapy | Gene silencing | HSF cells | 178 |
| MN | Reactive oxygen species (ROS)-responsive; excellent biocompatibility and biodegradability | Diatomaceous earth (DE) | Acne vulgaris therapy | Controlled and sustained drug release | Infiltrated inflammation cells; P. acnes; P. acnes-induced mice | 179 |
| MN | Degradability; biocompatibility | Rosi-loaded NPs | Obesity therapy | Sustained release | C57BJ/6 mice | 181 |
| MN | Biocompatibility; rapid Dissolvability | DNA vaccine coated PLGA-PLL/Γpga NPs | Ebola vaccination | Supporting the safety and immunogenicity of the vaccine | HeLa cells | 67 |
| MN | Flexibility; dissolvability | DNA polyplex | Porcine circovirus Type 2 | Stronger immune response; excellent vaccine stability | normal mouse | 185 |
| MN | Biocompatibility; dissolvability | DNA loaded RALA peptide NPs | Cervical cancer | Enhanced immune responses | C57BL/6 mice | 186 |
| MN | Dissolvability; sufficient mechanical strength | pOVA loaded nanopolyplex | Melanoma | Stronger antigen-specific antibody response; enhanced antibody recall memory after challenge | DC 2.4 cells; RAW 264.7 cells; C57BL/6 mic | 187 |
| Hydrogel | High intrinsic bioactivity; excellent mechanical strength, | Ultrathin 2D black phosphorus (BP) nanosheets; CaP crystal particles | Bone-tissue regeneration | Mimics biological mineralization | hBMSCs cells, MC3T3 cells | 36 |
| Hydrogel | Good biocompatibility | Gold-spiked silica microrods | Anti-bacteria | Plasmonic-induced photothermal anti-bacteria | E. coli | 39 |
| Hydrogel | Good biocompatibility; controllable porosity; degradability; swelling, rheological, mechanical, and conductive behaviors | Polydopamine-coated carbon nanotubes (CNT-PDA) | Wound healing | Photothermal anti-bacteria | L929 fibroblast cells; | 45 |
| Hydrogel | Excellent biocompatibility and biological properties; improved mechanical properties | Ferritin nanocage | Tissue regeneration | pH stimulus; less cellular toxicity; good cellular growth, controllable and sustained drug release | NIH-3T3 cells | 46 |
| Hydrogel | Enhanced viability; mitigated hypoxia-induced cell death | Calcium peroxide (CPO) | Infarcted myocardial tissue regeneration | Controlled oxygen release | Photoinitiator (Irgacure 2959) | 47 |
| Hydrogel | Improved organization, electroactivity, mechanical integrity; improved cardiac cell adhesion, organization, and cell-cell coupling | Carbon nanotube (CNT) | Cardiac constructs | Promote electroactive tissue repair | MSCs cells | 48 |
| Hydrogel | Biocompatible paintable conductive, strong wet adhesive property | Polypyrrole (Ppy) nanoparticles | Cardiac tissue reconstruction | Faster self-degradation | L929 cells, BMSCs cells; SD rats | 64 |
| Hydrogel | Excellent operation ability; biocompatibility and most importantly | Stem cell-derived exosomes (SC-Exos) | Wound repair | Photoinduced imine crosslinking | New Zealand rabbits | 88 |
| Hydrogel | Biodegradability and biocompatibility; self-adhesive and conductive | Dopamine-functionalized polypyrrole (DA−PPy) | Infarcted myocardium construction | Biocleavable; mechanical supporting | L929 cells, H9C2 cardiomyocytes; SD rats | 91 |
| Hydrogel | Excellent antibacterial activity | Silver nanoparticles | Wound healing | Metal ion induced anti-bacteria | 155 | |
| Hydrogel | Relevant swelling capacity, good biocompatibility and mechanical properties | Silver nanoparticles | Wound healing | pH-Responsive; metal ion induced anti-bacteria | 157 | |
| Hydrogel | Excellent antibacterial properties; excellent injectability; biocompatibility | Zinc-doped bioactive glass (ZBG)/succinyl chitosan (SCS)/oxidized alginate (OAL) composite hydrogels (Gel-ZBG) | Wound healing | Metal ion induced anti-bacteria | L929 cells; | 158 |
| Hydrogel | High antibacterial efficiency | Ag/Ag@AgCl/ZnO hybrid nanostructures | Wound healing | Reversible swelling-shrinking transition by pH; metal ion induced anti-bacteria | MC3T3-E1 cells; | 159 |
| Hydrogel | Good mechanical stability; excellent tissue adhesion; self-healing properties | PF127 nano micelles | Wound healing | Antibiotic anti-bacteria | E. coli, | 160 |
| Hydrogel | Stretchable compressible; self-healing injectable; pH-dependent biodegradation and release behavior, | PF127–CHO micelles (Cur-PF127-CHO) | Wound healing | Antibiotic anti-bacteria | E. coli, | 161 |
| Hydrogel | Excellent mechanical properties | Diacrylated Pluronic F127 micelles | Wound healing | Mechano-responsive; antibiotic anti-bacteria | S.epidermidis, E. coli; rabbit BMSCs | 162 |
| Hydrogel | Prevented multidrug resistance; minimized drug toxicity | Fe3O4@C nanoparticles | Wound healing | Visual and real-time monitoring of drug content; antibiotic anti-bacteria | L929 cells; | 163 |
| Hydrogel | Inherent antimicrobia; antioxidant; cytocompatibility properties | silver Nanoparticles | Wound healing | Antibiotic anti-bacteria | S.aureus, P. acnes and Candida auris | 164 |
| Hydrogel | Superior antibacterial capacity; reduced inflammatory response; promoted angiogenesis ability | Cu nanoparticles (Cu NPs) | Wound healing | Photothermal anti-bacteria | NIH-3T3 cells; | 165 |
| Hydrogel | Excellent and controlled photothermal ability | Oligomeric proanthocyanidins (OPC) | Wound Healing | Photothermal anti-bacteria l | B16F10 cells, nude Balb/c mouse; STZ diabetic C57BL/6 mouse | 166 |
| Hydrogel | Injectable photo–cross linked; biodegradability; biocompatibility; protection of loaded drugs | PLGA nanoparticles | Bone tissue repair | Sustained release | MSCs cells | 167 |
| Hydrogel | Improved strength and conductivity | Carbon nanotubes (CNTs) | Cardiac constructs | Improved cardiac cell functions | LX-2 cells; SD rats | 169 |
| Hydrogel | Injectable; sustainable; thermoresponsive | Copper sulfide nanodots | Obesity therapy | NIR-II photothermal-responsive | Primary human white preadipocytes; high-fat-diet fed mice | 182 |
| Fiber | Enhanced mechanical properties, wettability, thermal stability, biominerals deposition, and biocompatibility, proliferation and differentiation behavior | 2D MoS2 nanosheets | Bone tissue regeneration | Thermal induced decomposition | MC3T3-E1 cells | 38 |
| Fiber | Enhanced cell adhesion, growth, proliferation; enhanced bioactivity, biocompatibility and osteogenic differentiation | Polypyrrole nanoparticles (PPy–NPs) | Bone tissue regeneration | Electrical stimulation | MC3T3-E1 cells | 118 |
| Fiber | Strong biocompatibility, bactericidal, porous and mechanically | Silver nanoparticle | Wound healing | Metal ion induced anti-bacteria | NIH3T3 cells; | 156 |
| Microcapsule | Biocompatibility and biodegradability | PLGA microcapsules | Tissues regeneration | Mechano-activation | MSCs cells | 115 |
Comparison for advantages and disadvantages of different flexible polymeric patches.
| Polymeric matrix | Advantages | Disadvantages |
|---|---|---|
| MN | Precise drug loading; | Need more waiting-time to completely dissolve before removing the patch; |
| Hydrogel | High drug loading efficiency; | Polymer residues found in skin within a few days; |
| Microsphere/microcapsule | Increasing drug loading efficiency through encapsulation or coating; | Polymer residues found in skin within a few days; |
Fig. 1A) Schematic Illustration of microneedles fabrication by PDMS cast molding. Reprinted with permission from Ref. [67]. Copyright 2017, Wiley. B) A schematic illustrating the design of the PVP MN arrays containing pH-responsive pH-responsive hollow microspheres (HMs) and the mechanism for delivering of two different drugs. PLGA: poly(D,L-lactic-co-glycolic acid). DiI: (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate). Reprinted with permission from Ref. [70]. Copyright 2012, Elsevier. C) Illustration of the active delivery MN containing Mg particles, where contact with bodily fluids releases H2 gas that act as “pumps”. Reprinted with permission from Ref. [71]. Copyright 2019, Wiley.
Fig. 2A) Schematic illustration of the fabrication of GelMA hydrogels and the oxygen generation from encapsulated CPO. The GelMA hydrogels were prepared by mixing GelMA, CPO and cardiac side population cells (CSPs) via photopolymerization. Reprinted with permission from Ref. [47]. Copyright 2017, American Chemical Society. B) Illustration of the modification of black phosphorus (BP) nanosheets with polydopamine (PDA) and the incorporation of the BP@PDA nanosheets into GelMA hydrogel (GelMA-BP@PDA hydrogel). Reprinted with permission from Ref. [100]. Copyright 2020, Wiley.
Fig. 3Illustrative fabrication of hypoxia and H2O2 dual-sensitive polymersome-based vesicles (d-GRPs) loading MN patches, A) Mechanism of preparing d-GRPs coated by PEG-poly(Ser-S-NI); B) scheme for descripting local inflammation induced by non–H2O2–sensitive GRP-loaded MN patch, and d-GRP-loaded MN patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [145]. Copyright 2017, American Chemical Society.
Fig. 4A) Schematic description of synthesizing Mimic multi-enzyme ins/GOx@Co-ZIF-8 and MOF-based MNs for glucose-mediated transdermal insulin release, (a1) Illustration of preparing multi-enzyme ins/GOx@Co-ZIF-8, (a2) schematic depiction of MOF-based MNs for transdermal insulin release. Reprinted with permission from Ref. [40]. Copyright 2020, American Chemical Society. B) Schematic illustration of vesicles for glucose mediated insulin delivery, (b1) illustrative formation and degraded mechanism of mPEG-bP(Ser-PBE), (b2) schematic description of the self-assembly of PVs loaded with insulin and GOx and their dissociation to release insulin under a hyperglycemic condition, (b3) illustrative diagram of PVs-based MNs patches for smart insulin delivery in a mouse model of type 1 diabetes. Reprinted with permission from Ref. [75]. Copyright 2017, American Chemical Society. C) Scheme of H2O2 and pH -responsive NC-loading MN-array patch for in vivo insulin delivery, (c1) illustrated description of preparing H2O2 and pH cascade-responsive NC-loading MN-array patch, (c2) schematic route for polymer synthesis, (c3) illustration of NC-containing MN-array patch for in vivo insulin delivery under a hyperglycemic state. Reprinted with permission from Ref. [154]. Copyright 2018, Wiley.
Fig. 5A) Illustrative description of Ag/Ag@AgCl/ZnO hybrid nanostructures embedded hydrogel and the mechanism for wound healing by photo-inspired antibacterial. Reprinted with permission from Ref. [165]. Copyright 2017, American Chemical Society. B) Schematic illustration of hydrogel-functionalized textiles for optical screen of drug release and wound healing, (b1) preparation process of thermochromic hydrogel-functionalized textiles and the principle of drug release, (b2) optical photos of hydrogel-functionalized textiles with antibiotic loading or release. Reprinted with permission from Ref. [169]. Copyright 2019, American Chemical Society. C) Schematics of OPC-embedded hydrogel scaffolds for wound healing and melanoma therapy. Reprinted with permission from Ref. [172]. Copyright 2020, American Chemical Society. D) Scheme of NIR responsive separable MNs encapsulated with BP QDs and oxygen carrying Hb for wound healing. Reprinted with permission from Ref. [37]. Copyright 2020, American Chemical Society.
Fig. 6A) Schematic illustration of BP NSs incorporated hydrogels for upregulated bone formation, (a1) illustrative preparation of double network (DN) hydrogels with different strength, (a2) bioactive nanoengineered (NE) hydrogels composition of black BP NSs and CaP matrix formation in DN hydrogels for bone regenerations. Reprinted with permission from Ref. [36]. Copyright 2019, Wiley. B) Scheme for preparing a conductive and adhesive hydrogel for painting directly on the surface of MI heart in SD rats. Reprinted with permission from Ref. [64]. Copyright 2018, Wiley.
Fig. 7A) Illustrative fabrication and mechanism of a ROS-responsive microneedle patch for acne vulgaris treatment. Reprinted with permission from Ref. [185]. Copyright 2018, Wiley. B) Schematic of a detachable microneedle patch for hair loss therapy, (b1) illustrative depiction of Keratin that used to form the polymeric matrix of MNs, (b2) schematics of keratin hydrogel-based MNs encapsulated with MSC-derived exosomes and UK5099-loaded PLGA NPs, (b3) illustrative process of MNs applying to the skin for sustained release of therapeutics, (b4) schematic description of transdermal delivery of HFSC for accelerating a new hair cycle transition and hair regrowth. Reprinted with permission from Ref. [77]. Copyright 2019, American Chemical Society. C) Schematic illustration of transcutaneous MN patch loaded with NPs comprised of Rosi, GOx, CAT and pH-sensitive acetal-modified dextran for the brown remodeling of the white fat. Reprinted with permission from Ref. [186]. Copyright 2017, American Chemical Society.